跳至主要内容
临床试验/IRCT20190128042520N7
IRCT20190128042520N7招募中3 期

The impact of prophylactic pantoprazole dosage on the occurrence of marginal ulcer following one anastomosis gastric bypass surgery in patients with severe obesity

Iran University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with a Body Mass Index (BMI) of 40 or more
  • Patients aged 18 to 65 years
  • Insensitivity to pantoprazole
  • Patients who underwent primary single anastomotic bypass surgery

排除标准

  • Patients who do not want to continue the study and withdraw will be excluded from the study.
  • Patients who are not able to continue the treatment due to special conditions at each stage of the plan.
  • Patients who show sensitivity due to the use of pantoprazole and side effects.
  • Patients who take aspirin, NSAIDs, corticosteroids, blood thinners, or oral anticoagulants.
  • Patients who smoke, hookah and any tobacco.
  • Patients who undergo a change in the prescription dose of pantoprazole due to the complication or the prescription of an antacid drug or H2 blocker at the same time.

研究者

相似试验